Lucera Erick — SEC insider filings
SEC reporting owner CIK 1697616. 31 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2021-03-03 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 41,266 shares, $29,199 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 39,771 shares, $394,598 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 60.
- Largest priced transaction: sale of 22,337 shares @ $5.61 ($125,404) in Editas Medicine, Inc., filed 2024-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | 7 | — | 5 legs · 13,325 sh · $262,164 | 4 |
| Editas Medicine, Inc. (EDIT) | EVP, CHIEF FINANCIAL OFFICER | 5 | — | 2 legs · 26,446 sh · $132,434 | 7 |
| Beyond Air, Inc. (XAIR) | Director | 10 | 2 legs · 41,266 sh · $29,199 | — | 37 |
| AVEO PHARMACEUTICALS, INC. (AVEO) | Chief Financial Officer | 3 | — | — | 5 |
| Bone Biologics Corp (BBLG) | Director | 3 | — | — | 4 |
| SAB Biotherapeutics, Inc. (SABS) | Director | 3 | — | — | 3 |
Insider filings — Lucera Erick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,991 @ $16.82 | EDGAR |
| 2026-08-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,797 @ $26.28 | EDGAR |
| 2026-06-26 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,362 @ $20.37 | EDGAR |
| 2026-05-14 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,448 @ $18.36 | EDGAR |
| 2026-04-03 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 5,727 @ $18.64 | EDGAR |
| 2026-02-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 2,250 (derivative) · Grant/award (A): 2,250 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Grant/award (A): 2,000 (derivative) · Disposition to issuer (D): 1,500 (derivative) · Grant/award (A): 1,500 (derivative) · +10 more | EDGAR |
| 2025-04-01 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 66,100 @ $0 · Grant/award (A): 214,500 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 275,100 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 4,109 @ $1.71 | EDGAR |
| 2024-11-26 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 45,000 (derivative) · Grant/award (A): 45,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Grant/award (A): 40,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Grant/award (A): 30,000 (derivative) · +8 more | EDGAR |
| 2024-08-15 | 4 | Beyond Air, Inc. (XAIR) | Purchase (P): 39,266 @ $0.40 | EDGAR |
| 2024-07-17 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Editas Medicine, Inc. (EDIT) | Sale (S): 22,337 @ $5.61 | EDGAR |
| 2024-03-21 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 35,300 @ $0 · Grant/award (A): 25,966 @ $0 · Grant/award (A): 106,000 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 85,763 (derivative) @ $0 | EDGAR |
| 2023-05-18 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 77,900 @ $0 · Grant/award (A): 155,800 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | SAB Biotherapeutics, Inc. (SABS) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-03-31 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Beyond Air, Inc. (XAIR) | Purchase (P): 2,000 @ $6.82 | EDGAR |
| 2023-03-08 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 36,845 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | AVEO PHARMACEUTICALS, INC. (AVEO) | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 218,800 (derivative) | EDGAR |
| 2022-03-07 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 2,949 (derivative) @ $0 · Grant/award (A): 8,722 (derivative) @ $0 | EDGAR |
| 2022-02-17 | 4 | AVEO PHARMACEUTICALS, INC. (AVEO) | Grant/award (A): 218,800 (derivative) @ $0 | EDGAR |
| 2021-04-16 | 4 | AVEO PHARMACEUTICALS, INC. (AVEO) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Beyond Air, Inc. (XAIR) | Option exercise (M): 1,171 @ $4.25 · Option exercise (M): 1,171 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1697616 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs